Fatigue and diabetes mellitus: a prospective study


  • Parminder Kaur Department of Medicine, Pt. BDS PGIMS Rohtak, Haryana, India
  • S. N. Chugh Department of Medicine, Pt. BDS PGIMS Rohtak, Haryana, India
  • Harpreet Singh Department of Medicine, Pt. BDS PGIMS Rohtak, Haryana, India
  • Vikram S. Tanwar Department of Medicine, SHKM Government Medical College, Nalhar, Haryana, India
  • Gagandeep Sukhija Department of Medicine, Pt. BDS PGIMS Rohtak, Haryana, India
  • Rekha Mathur Department of Medicine, Pt. BDS PGIMS Rohtak, Haryana, India




Blood glucose parameters, Blood glucose variability, Diabetes Mellitus, Fatigue, HbA1c, MFSI-SF


Background: Fatigue is a common complaint among patients with diabetes mellitus (DM) that can undermine the daily functional activities of a person. The objectives of the study were to assess the fatigue in patients of newly diagnosed type 2 DM and to relate fatigue with blood glucose parameters (BGP) and glycemic control.

Methods: A total 50 patients of type 2 DM, diagnosed as per American Diabetes Association 2011 criteria, were enrolled in the study group. Each subject was evaluated two times for fatigue using Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) scale. 1st assessment was at the time of enrollment and 2nd was done after achieving target control of type 2 DM. Values of Fasting blood glucose (FBG), postprandial blood glucose (PPBG), blood glucose variability (BGV) and glycosylated hemoglobin (HbA1c) were obtained for each subject at each assessment. Data collected was analyzed statistically.

Results: Mean age of study group was 50.7±8.9 years with male to female ratio of 1.17:1. Mean values of MFSI-SF score at 1st and 2nd assessment were 14.10±17.97 and 4.64±14.06, respectively indicating a statistically significant improvement in fatigue (p<0.05) after achieving target control. Overall fatigue, general fatigue, emotional fatigue, and vigor score correlated significantly with glycemic control (HbA1c) with correlation coefficient (r) of 0.337, 0.351, 0 .339, and - 0.281, respectively (all p <0.05).

Conclusions: Fatigue had a positive correlation with FBG, PPBG and BGV and HbA1c. A significant improvement in all the parameters of fatigue was noted after control of diabetic status.


Alberti KG, Aschner P, Assal JP, Bennett PH, Groop L, Jervell J et al. Part 1: Diagnosis and classification of Diabetes Mellitus. In: Definition, diagnosis, and classification of Diabetes Mellitus and its Complication. Report of WHO consultation. World health organization, Department of Noncommunicable Disease Surveillance, Geneva; 1999.

Avlund K, Mehlsen MY, Thomsen DK, Viidik A, Zachariae R. Physical functioning and use of health services in a young and old sample. The influence of fatigue. Dan Med Bull. 2008;55(3):147-51.

Ditter AJ, Wessely SC, Brown RG.The assessment of fatigue. A Practical guide for clinicians and researchers. J Psychosom Res. 2004;57:429-39.

Stewart ST, Woodward RM, Rosen AB, Cutler DM. The impact of symptoms and impairments on overall health in US national health data. Med Care. 2008;46(9):954-62.

Nijrolder I, van der Windt DA, van der Horst HE. Prognosis of fatigue and functioning in primary care: A 1-year follow-up study. Ann Fam Med. 2008;6(6):519-27.

Drivsholm T, de Fine Olivarius N, Nielsen AB, Siersma V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia. 2005;48:210-14.

Fritschi C, Quinn L. Fatigue in patients with diabetes: a review. J Psychosom Res. 2010;69(1):33-41.

Powers AC. Diabetes Mellitus: Diagnosis, Classification and Pathophysiology. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Editors. Harrison’s principles of Internal medicine. 19th Ed. New York. McGrawHill; 2015:2399-2407.

Spitzer RL, Kroenke K, Williams JBW. Patient health questionnaire study group. validity and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282:1737-44.

Stein KD, Martin SC, Hann DM, Jacobsen PB. A multidimensional measure of fatigue for use with cancer patients. Cancer Practice. 1998;6:143-52.

Norma G, Cuellar DS, Sarah J Ratcliffe. A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome. J Clin Sleep Med. 2008;4(1):50-6.

Weijman I, Kant I, Swaen GM. Diabetes, employment and fatigue-related complaints: A comparison between diabetic employees, "healthy" employees, and employees with other chronic diseases. J Occup Environ Med. 2004;46(8):828-36.

Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol Med. 1995;25(5):895-905.

De Sonnaville JJ, Snoek FJ, Colly LP, Deville W, Wijkel D, Heine RJ. Well-being and symptoms in relation to insulin therapy in type 2 diabetes. Diabetes Care. 1998;21(6):919-24.

Bulpitt CJ, Palmer AJ, Battersby C, Fletcher AE. Association of symptoms of type 2 diabetic patients with severity of disease, obesity, and blood pressure. Diabetes Care. 1998;21(1):111-5.

Warren RE, Deary IJ, Frier BM. The symptoms of hyperglycaemia in people with insulin-treated diabetes: Classification using principal components analysis. Diabetes Metab Res. 2003;19(5):408-14.

Sommerfield AJ, Deary IJ, Frier BM. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care. 2004;27(10):2335-40.

Nielsen AB, Gannik D, Siersma V, de Fine Olivarius N. The relationship between HbA 1c level, symptoms and self-rated health in type 2 diabetic patients. Scand J Primary Health Care. 2011;29:157-64.

Van der Does FE, De Neeling JN, Snoek FJ. Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care. 1996;19(3):204-10.

Monnier L, Mas E, Ginet C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.






Original Research Articles